When should a transthoracic echocardiogram be repeated in a patient with mild to moderate aortic regurgitation and mild to moderate pulmonic regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Echo Surveillance for Mild-Moderate Aortic and Pulmonic Regurgitation

For asymptomatic patients with mild to moderate aortic regurgitation and normal LV function, repeat echocardiography every 1-2 years; for mild AR with no LV dilatation, extend the interval to every 2-3 years. 1, 2, 3

Aortic Regurgitation Surveillance Strategy

The frequency of echo surveillance is driven by AR severity, LV dimensions, and systolic function:

For Mild AR (with little/no LV dilatation and normal systolic function):

  • Clinical evaluation: Yearly
  • Echocardiography: Every 2-3 years routinely 1
  • Yearly echo is unnecessary unless clinical evidence suggests worsening regurgitation 1

For Moderate AR (with normal systolic function):

  • Echocardiography: Every 1-2 years 2, 3, 4
  • This represents the most appropriate interval for your patient population

Initial Assessment Caveat:

If the chronicity of the regurgitation is uncertain at initial presentation, perform repeat physical exam and echo within 2-3 months to exclude a subacute process with rapid progression 1. Once stability is established, transition to the intervals above.

Pulmonic Regurgitation Surveillance

The guidelines provide limited specific guidance on isolated pulmonic regurgitation surveillance. However, applying the general valvular disease framework:

  • Mild-moderate PR: Follow similar intervals as for mild-moderate AR (every 1-2 years for moderate, every 2-3 years for mild) 2
  • Focus on RV size and function assessment, as these are the key hemodynamic consequences

Key Monitoring Parameters

At each surveillance echo, assess:

  • LV dimensions: End-diastolic dimension (normal <60mm) and end-systolic dimension (normal <50mm) 1
  • LV systolic function: LVEF (normal ≥50%)
  • RV size and function: For the pulmonic regurgitation component
  • Pulmonary artery systolic pressure
  • Progression of regurgitation severity

Triggers for Earlier Repeat Echo

Perform echo sooner than scheduled if:

  • New or worsening symptoms develop
  • Equivocal history of changing exercise tolerance 1
  • Clinical findings suggest worsening regurgitation on exam
  • Aortic root dilatation is present (requires separate aortic surveillance) 1

Practical Algorithm

  1. Establish baseline: Comprehensive echo documenting severity, LV/RV dimensions, and function
  2. Determine chronicity: If uncertain, repeat in 2-3 months
  3. Set surveillance interval:
    • Moderate AR → Every 1-2 years
    • Mild AR with normal LV → Every 2-3 years
    • Apply similar logic to PR based on severity
  4. Annual clinical visits regardless of echo timing
  5. Accelerate surveillance if symptoms emerge or clinical deterioration occurs

Important Caveats

The 2022 systematic review 2 confirms consensus across ACC/AHA, ESC, and JCS guidelines that mild-moderate AR warrants 1-2 year follow-up intervals, with mild AR extending to 3-5 years in some recommendations. The more conservative 1-2 year interval for moderate disease and 2-3 years for mild disease represents the safest approach given the risk of progressive LV remodeling that can occur asymptomatically.

Combined valve disease may necessitate shorter intervals than recommended for isolated lesions, as the hemodynamic burden is additive. In your patient with both AR and PR, err toward the more frequent surveillance schedule (every 1-2 years) to capture any progressive ventricular remodeling from the combined volume load.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.